BioIncept is a pharmaceutical company that develops and commercializes novel therapeutics for the treatment of diabetes and autoimmune diseases. BioIncept was founded in 2001. BioIncept's headquarters is located in New York, New York, USA 10017.
There have been no acquisitions found related to BioIncept
Recent investment data cannot be found related to BioIncept